The effect of SARS-CoV-2 double vaccination on the outcomes of hemodialysis patients with COVID-19: A meta-analysis

[1]  Irina Isakova-Sivak,et al.  Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza , 2022, Expert review of vaccines.

[2]  S. Mezzano,et al.  Clinical Efficacy of SARS-CoV-2 Vaccination in Hemodialysis Patients , 2022, Kidney International Reports.

[3]  A. Salama,et al.  Outcome and effect of vaccination in SARS-CoV-2 Omicron infection in hemodialysis patients: a cohort study , 2022, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  O. Pybus,et al.  Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa , 2022, Nature Medicine.

[5]  S. Fujitani,et al.  Low SARS-CoV-2 antibody titers may be associated with poor clinical outcomes for patients with severe COVID-19 , 2022, Scientific Reports.

[6]  A. Salama,et al.  Severity of COVID-19 after Vaccination among Hemodialysis Patients , 2022, Clinical journal of the American Society of Nephrology : CJASN.

[7]  M. Nangaku,et al.  Effectiveness of SARS‐CoV‐2 vaccines on hemodialysis patients in Japan: A nationwide cohort study , 2022, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[8]  A. Monto,et al.  Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022 , 2022, medRxiv.

[9]  Yushu Wang,et al.  Lack of efficacy for sotrovimab use in patients with COVID-19: A meta-analysis , 2022, Journal of Infection.

[10]  K. Kikuchi,et al.  Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients , 2022, Clinical and Experimental Nephrology.

[11]  M. Edmond,et al.  Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis , 2022, Journal of Infection.

[12]  L. Juillard,et al.  A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis , 2021, Kidney International.

[13]  Guilhem Cavaillé,et al.  Efficacy of the BNT162b2 mRNA COVID-19 vaccine in a haemodialysis cohort. , 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  Hui Tang,et al.  Risk factors for the mortality of hemodialysis patients with COVID‐19: A multicenter study from the overall hemodialysis population in Wuhan , 2021, Seminars in dialysis.

[15]  M. Zeier,et al.  Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2 , 2021, Clinical journal of the American Society of Nephrology : CJASN.

[16]  Guilhem Cavaillé,et al.  Efficacy of the BNT162b2 mRNA Covid-19 Vaccine in a hemodialysis cohort , 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  M. Gao,et al.  Risk factors for mortality in hemodialysis patients with COVID-19: a systematic review and meta-analysis , 2021, Renal failure.

[18]  M. Pirklbauer.  Hemodialysis treatment in patients with severe electrolyte disorders: Management of hyperkalemia and hyponatremia , 2020, Hemodialysis international. International Symposium on Home Hemodialysis.

[19]  M. Betjes.  Immune cell dysfunction and inflammation in end-stage renal disease , 2013, Nature Reviews Nephrology.